Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adapalene Gel 0.3% vs Differin in Acne Vulgaris
NCT02411942Phase 1Completed
- Start
- Aug 2014
- Primary completion
- Feb 2015
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of adapalene in acne vulgaris (3 arms). Primary endpoints: Change in inflammatory lesion counts at 12 weeks and Change in non-inflammatory lesion counts at 12 weeks. Started Aug 2014; status: completed.
02
Drugs
adapalene
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT02411942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02411942.